CLINICAL_TRIALS
trial_result
· 2013-02-21
Clinical Trial Update: A Study to Evaluate the Duration of LASTACAFT® in Acute Allergic Conjunctivitis [Phase 4]
Summary
Phase 4 study evaluating the duration of LASTACAFT (alcaftadine) in acute allergic conjunctivitis was completed. The results were posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allergan | Conditions: Conjunctivitis, Allergic | Phase 4 | Status: COMPLETED | Results posted: 2013-02-21